Clarivate (CLVT) Q3 2025

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025

Earnings

Clarivate delivered a clear beat in Q3 2025, with adjusted diluted EPS of $0.18 topping the $0.16 consensus estimate by 15.09% and revenue of $623.10 million clearing expectations of $570.35 million by 9.25%, even as total sales held nearly flat year… Read more Clarivate delivered a clear beat in Q3 2025, with adjusted diluted EPS of $0.18 topping the $0.16 consensus estimate by 15.09% and revenue of $623.10 million clearing expectations of $570.35 million by 9.25%, even as total sales held nearly flat year-over-year at just +0.1%. The standout driver behind the revenue outperformance was a surge in transactional book sales ahead of a planned June 2026 disposal, which also prompted management to raise its full-year 2025 revenue outlook to $2.42 billion-$2.46 billion from a prior range of $2.28 billion-$2.40 billion. Organic ACV growth accelerated 30 basis points sequentially to 1.6%, renewal rates improved 100 basis points to 93%, and recurring revenue mix expanded to 88% on a year-to-date organic basis, underscoring the company's deliberate pivot toward higher-quality subscription revenue. Despite the top-line strength, Adjusted EBITDA slipped to $252.40 million from $264.40 million a year ago, with margin compressing 200 basis points to 40.5%, pressured by higher incentive compensation and ongoing product investment. With a strategic alternatives review conclusion expected in February 2026, investors are watching closely for signals on the company's longer-term direction.